Home › Funds › Renaissance Technologies › STAB

Renaissance Technologies position in STAB

STATERA BIOPHARMA INC

Latest position (Q4 2022)722.39K sh
Reported value held$59
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q3 2021 114.20K $264.00K New
Q4 2021 206.03K $474.00K Add
Q1 2022 171.92K $54.00K Reduce
Q2 2022 1.64M $466.00K Add
Q3 2022 1.36M $176.00K Reduce
Q4 2022 722.39K $59 Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding STAB

No other tracked fund reports a position in STAB.

All STAB fund holders →